Invention Grant
- Patent Title: Treatment of Ras-expressing tumors
- Patent Title (中): 治疗表达Ras的肿瘤
-
Application No.: US12298436Application Date: 2007-04-13
-
Publication No.: US09539303B2Publication Date: 2017-01-10
- Inventor: William McCulloch , Mitchell Keegan
- Applicant: William McCulloch , Mitchell Keegan
- Applicant Address: US NJ Summit
- Assignee: Celgene Corporation
- Current Assignee: Celgene Corporation
- Current Assignee Address: US NJ Summit
- Agent Jones Day
- International Application: PCT/US2007/009294 WO 20070413
- International Announcement: WO2008/013589 WO 20080131
- Main IPC: A61K38/12
- IPC: A61K38/12 ; A61K31/7068 ; A61K38/15 ; A61K45/06
Abstract:
The present invention provides compositions and methods for the treatment of /?αs-expressing tumors using at least one DAC inhibitor (e.g., romidepsin).
Public/Granted literature
- US20090305956A1 Treatment of Ras-Expressing Tumors Public/Granted day:2009-12-10
Information query
IPC分类:
